Company / Current Liabilities
ABEONA THERAPEUTICS INC. Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$29.6M
FY2025
5-year range
$7.8M / $29.6M
FY2021-FY2025
Trend
+78.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has increased for 3 consecutive years, from $8M in FY2022 to $30M in FY2025.
Based on SEC 10-K filings.
$30M in FY2025 with a 5-year CAGR of -6.8%.
Increased from $13M to $30M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +56.1%
- 5-Year CAGR
- -6.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- ABEONA THERAPEUTICS INC.'s current liabilities has grown for 3 consecutive years.
- 5-year CAGR of -6.8%, indicating a declining trend.
- In FY2025, current liabilities increased 78.3% year-over-year.
- Peak current liabilities was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -2.42 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $29.6M | +78.3% |
| FY2024 | $16.6M | +23.6% |
| FY2023 | $13.4M | +72.5% |
| FY2022 | $7.8M | -53.2% |
| FY2021 | $16.6M | -60.4% |
| FY2020 | $42.0M | +8.4% |
| FY2019 | $38.7M | +90.1% |
| FY2018 | $20.4M | +263.0% |
| FY2017 | $5.6M | -32.4% |
| FY2016 | $8.3M | +461.7% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026